Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapies (chemoimmunotherapy) is associated with significantly better survival outcomes than cytotoxic chemotherapies alone in patients with advanced non-small cell lung cancer (NSCLC). However, there are no prognostic markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Satomi, Uchino, Junji, Yokoi, Takashi, Kijima, Takashi, Goto, Yasuhiro, Suga, Yoshifumi, Katayama, Yuki, Nakamura, Ryota, Morimoto, Kenji, Nakao, Akira, Hibino, Makoto, Tani, Nozomi, Takeda, Takayuki, Yamaguchi, Hiroyuki, Tachibana, Yusuke, Takumi, Chieko, Hiraoka, Noriya, Takeshita, Masafumi, Onoi, Keisuke, Chihara, Yusuke, Taniguchi, Ryusuke, Yamada, Takahiro, Matsui, Yohei, Hiranuma, Osamu, Morimoto, Yoshie, Iwasaku, Masahiro, Tokuda, Shinsaku, Kaneko, Yoshiko, Yamada, Tadaaki, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870759/
https://www.ncbi.nlm.nih.gov/pubmed/35204513
http://dx.doi.org/10.3390/diagnostics12020423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870759/
https://www.ncbi.nlm.nih.gov/pubmed/35204513
http://dx.doi.org/10.3390/diagnostics12020423

Ejemplares similares